Cargando…
A current review of folate receptor alpha as a potential tumor target in non-small-cell lung cancer
Lung cancer remains the leading common cause of cancer-related death, with non-small-cell lung cancer (NSCLC) accounting for 80% of all cases. To date, platinum-based doublet chemotherapy is the cornerstone of first-line therapy. However, these agents have limited use in patients who have relapsed a...
Autores principales: | Shi, Huan, Guo, Jun, Li, Changzheng, Wang, Zhehai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4560517/ https://www.ncbi.nlm.nih.gov/pubmed/26357465 http://dx.doi.org/10.2147/DDDT.S90670 |
Ejemplares similares
-
Targeting folate receptor alpha for cancer treatment
por: Cheung, Anthony, et al.
Publicado: (2016) -
Folate Receptor Alpha Expression in Lung Cancer: Diagnostic and Prognostic Significance
por: O'Shannessy, Daniel J., et al.
Publicado: (2012) -
Folate Receptor Targeted Alpha-Therapy Using Terbium-149
por: Müller, Cristina, et al.
Publicado: (2014) -
Folate Receptor Targeted Alpha-Therapy Using Terbium-149
por: Müller, Cristina, et al.
Publicado: (2014) -
Folate receptor-targeted near-infrared photodynamic therapy for folate receptor-overexpressing tumors
por: Aung, Winn, et al.
Publicado: (2022)